Carver Engineer Manufacturer

Elen Consulting is a San Diego-based company specializing in providing employment services and project management solutions. Led by a team of experienced professionals, including Anton Nathanson, Cory Murphy, David Wolf, Dmitriy Nathanson, and Stephane Beauvais, the company offers a range of consulting services to meet the needs of businesses in various industries. With a focus on delivering exceptional results, Elen Consulting leverages its expertise to help clients optimize their operations and achieve their goals. Through their comprehensive approach and commitment to excellence, the company has established itself as a trusted partner in the San Diego business community.Generated from the website

T. C. Construction Company is a San Diego based Class A General Contracting firm specializing in the construction, storage and conveyance of water, wastewater, sewage, demolition and other by-products. Its areas of operation include San Diego, Riverside and Imperial Counties and completes approximately 50 projects per year. Such facilities include concrete channels, box culverts, pump stations and water reservoirs. T.C. has established itself as a leader in the Southern California construction industry, with more than $500,000,000 in construction activity over the 25 years. It was awarded the prestigious Contractor of the Year award in 1999 by the Engineering General Contractor s Association (EGCA).

MediciNova is a publicly traded biopharmaceutical company focused on acquiring and developing novel small-molecule therapeutics for the treatment of diseases with unmet need with a specific focus on the United States market. Through strategic alliances primarily with Japanese pharmaceutical companies, MediciNova holds rights to a diversified portfolio of clinical and preclinical product candidates, each of which it believes has a well-characterized and differentiated therapeutic profile, attractive commercial potential and patent assets having claims of commercially adequate scope. The company s pipeline includes six clinical-stage compounds for the treatment of status asthmaticus, multiple sclerosis, asthma, interstitial cystitis, solid tumor cancer, generalized anxiety disorder, preterm labor and urinary incontinence and two preclinical-stage compounds for the treatment of thrombotic disorders. Its current strategy is to focus its resources on the development and commercialization of two prioritized assets in its development pipeline, MN-221 for the treatment of status asthmaticus and MN-166 for the treatment of multiple sclerosis. MediciNova maintains a location in San Diego, Calif.